Tarsons Products Limited (TARSONS) — Board Meeting

· NSE 🟡 Notable Neutral

Tarsons Products Limited announced completion of the second tranche of its approved EUR 3,000,000 equity investment in wholly-owned Singapore subsidiary Tarsons Life Science Pte. Ltd., subscribing to 184 shares at EUR 3,000 nominal value for a total of EUR 552,000 on June 03, 2026, to fund loan repayments and operational needs in its Singapore entity.

📄 View Original Announcement (PDF)

About Tarsons Products Limited (TARSONS)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹1,101.1 Cr P/E: 36.9

View full TARSONS stock details →

📡 Get AI alerts when TARSONS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TARSONS — Free

📊 More TARSONS filings

See all TARSONS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when TARSONS files new disclosures

Track TARSONS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TARSONS — Free

Free account · 2 AI queries/day